Inhaler Corticosteroid Device Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Inhaler Corticosteroid Device Market By 2029?

The inhaler corticosteroid device market size has witnessed strong expansion in recent years. It is anticipated to increase from $15.75 billion in 2024 to $16.83 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.9%. This past growth can be attributed to several factors including escalating healthcare expenditure, a growing elderly demographic, supportive governmental frameworks, continuous research and development endeavors, and elevated disposable income levels.

The inhaler corticosteroid device market size is projected to experience substantial expansion over the next few years. It is anticipated to reach $21.77 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.6%. This growth during the forecast period is primarily driven by factors such as an increase in respiratory disorders, greater awareness of respiratory health, significant investments in respiratory technologies, a rising focus on general health awareness, and increasing addiction to smoking. Prominent trends expected in the forecast period include the integration of smart technologies, the development of combination therapies, digital inhalers that offer real-time data, advancements in inhaler technology, and the use of data analytics in inhaler devices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25794&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Inhaler Corticosteroid Device Industry?

The escalating occurrence of respiratory ailments is projected to boost the expansion of the inhaler corticosteroid device market in the future. Respiratory diseases encompass various conditions impacting the lungs and airways, hindering individuals’ ability to breathe effectively and smoothly. The incidence of respiratory diseases is increasing because of rising air pollution, which exposes people to detrimental particles that harm lung tissue and provoke chronic conditions like asthma and bronchitis. Inhaler corticosteroid devices serve to manage respiratory diseases by directly delivering anti-inflammatory medicine to the lungs, thereby aiding in the reduction of inflammation and enhancement of respiration. As an illustration, in June 2025, data from the Office for Health Improvement and Disparities, a UK-based government department, indicated that in the financial year ending 2024, England documented 854,922 emergency hospital admissions attributed to respiratory diseases. This corresponded to a rate of 1,428 (ranging from 1,424 to 1,432) per 100,000 population, signifying a 7% rise compared to the preceding year. Consequently, the escalating occurrence of respiratory diseases is propelling the expansion of the inhaler corticosteroid device market.

What Are The Segment Types Shaping The Inhaler Corticosteroid Device Market?

The inhaler corticosteroid device market covered in this report is segmented –

1) By Product Type: Metered-Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers

2) By Formulation Type: Fluticasone Propionate, Budesonide, Beclomethasone, Mometasone Furoate

3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Direct Sales, Hospital Pharmacies

4) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Applications

5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Metered-Dose Inhalers: Conventional Metered-Dose Inhalers, Breath-Actuated Metered-Dose Inhalers, Spacer-Integrated Metered-Dose Inhalers

2) By Dry Powder Inhalers: Single-Dose Dry Powder Inhalers, Multi-Dose Dry Powder Inhalers, Reservoir Dry Powder Inhalers

3) By Soft Mist Inhalers: Manual Soft Mist Inhalers, Battery-Operated Soft Mist Inhalers

How Are Emerging Market Trends Shaping The Inhaler Corticosteroid Device Industry Landscape?

Leading companies within the inhaler corticosteroid device market are focusing on introducing innovative solutions, such as rescue inhalers that combine albuterol and budesonide to improve treatment effectiveness and provide patients with a more convenient, dual-action therapy in a single device. An inhaler combining albuterol and budesonide refers to a dual-action rescue inhaler that delivers both a bronchodilator (albuterol) for quickly opening airways and a corticosteroid (budesonide) for reducing inflammation, offering rapid symptom relief and long-term control of asthma from one device. For instance, in January 2024, AstraZeneca PLC, a UK-based pharmaceutical industry company, launched AIRSUPRA, the first and only FDA-approved rescue inhaler combining albuterol and budesonide for adults with asthma. This inhaler is designed for as-needed use to both alleviate acute bronchoconstriction symptoms and decrease airway inflammation, thereby reducing the risk of severe asthma exacerbations. It represents a novel approach by integrating a short-acting beta2-agonist (albuterol) with an inhaled corticosteroid (budesonide) in a single inhaler, approved based on clinical trials that demonstrated its superior efficacy over albuterol alone in preventing asthma attacks.

Who Are The Primary Competitors In The Global Inhaler Corticosteroid Device Market?

Major companies operating in the inhaler corticosteroid device market are AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Teijin Pharma Limited, Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals Inc., Mundipharma International Limited, Lupin Limited, Zydus Lifesciences Limited, Recipharm AB, Glenmark Pharmaceuticals Limited, Orion Corporation, Beximco Pharmaceuticals Limited, PARI Medical Holding GmbH, Kos Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/inhaler-corticosteroid-device-global-market-report

Which Regional Markets Are Contributing Most To The Inhaler Corticosteroid Device Industry Expansion?

North America was the largest region in the inhaler corticosteroid device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhaler corticosteroid device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Inhaler Corticosteroid Device Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25794&type=smp

Browse Through More Reports Similar to the Global Inhaler Corticosteroid Device Market 2025, By The Business Research Company

Infectious Disease Diagnostics Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Point Of Care Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

Dna Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795